In recent weeks, the early results of a cannabis-coronavirus trial have surfaced in popular publications. But have the facts been sensationalized?
Biota Biosciences, a Seattle-based CBD oil manufacturer and distributor, is voluntarily recalling several of its products after receiving a warning letter from the FDA last month.
The researchers believe these substances date back more than 2,700 years and were burned in order to induce a high among worshippers.
The findings add further weight to the case for using medical cannabis as a substitute for illicit opioids.
In light of other studies that have found similar associations, the research could still have vital implications for public health approaches to cannabis legalization.
The cannabis testing company hopes that by being transparent about its experience it can help other cannabis businesses navigate Covid-19 outbreaks.
The new study suggests that such non-medical, commercial hemp oil can help treat neuropathic pain.
Banning the import of hemp-derived CBD oil from European Union member states may contradict the EU law on the free movement of goods, according to an advisor to the Court of Justice of the European Union.